Saturday, Apr 20 2024 | Time 01:06 Hrs(IST)
image
Business EconomyPosted at: Oct 21 2020 11:23AM


Cyclica to use Excelras GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification

HYDERABAD, India and TORONTO, Oct. 21, 2020 /PRNewswire/ -- Excelra, a leading global Data & Analytics organization, today announced that it has licensed its Global Online Structure Activity Relationship Database (GOSTAR) to Cyclica Inc., a leading biotechnology company whose AI-augmented integrated platform enables multi-objective, polypharmacology-informed design of drug molecules.
GOSTAR is the largest online structure activity relationship database comprising of over 5.5 million small molecules and their associated chemical, biological and pharmacological properties. The database is manually curated by our scientific team who excerpt and enrich datasets from functional assays, in vitro and in vivo studies. A variety of small molecule activities encompassing SAR, physicochemical, metabolic, ADME and toxicological profiles are captured and structured into a relational database. GOSTAR ultimately equips researchers with insights to generate novel ideas in drug design in the early as well as optimization stages of drug discovery.
Dr. Raveendra Dayam, Director, Chemistry Services, Excelra said: "GOSTAR provides access to more than 28 million experimentally determined quantitative interactions between small molecules and the vast druggable target space. Insights derived from these interactions complement Cyclica's polypharmacology approach in novel compound drug discovery. GOSTAR is a rich qualitative and quantitative dataset that is applied by many AI/ML companies and we are excited that the data will support Cyclica with its predictive analytics."
The breadth of data provided by GOSTAR will broaden the domain of applicability of Cyclica's models, as Dr. Stephen MacKinnon, VP of R&D at Cyclica indicates: "The collaboration with GOSTAR strengthens Cyclica's training data for our platform models by allowing Cyclica to annotate our proteome screening data, thus enhancing our predicted interaction capabilities. This will have a direct impact on the development of more precise and efficacious medicines for patients in need."
About Cyclica
Cyclica is the first company to approach polypharmacology with a structure-based, AI-augmented in silico discovery platform, centered on 'Ligand Design' and 'Ligand Express'. Powered by MatchMaker™, a proprietary deep learning proteome screening technology, and POEM™, an innovative supervised learning technology for predicting molecular properties. To know more, visit www.cyclicarx.com
About Excelra:
Excelra's data and analytics solutions empower innovation in life sciences from molecule to market. The Excelra Edge comes from a seamless amalgamation of proprietary data assets, domain expertise and data science to accelerate drug discovery and development. To know more, visit www.excelra.com
Media Contact:
Dorothy Paul – Director Marketing
Email: [email protected]
Logo: https://mma.prnewswire.com/media/692189/Excelra_Logo.jpg
(Disclaimer--Features may vary depending on the regions; subject to change without notice.)
Please log in to get detailed story.
Tags: #Cyclica to use Excelras GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification
More News

"CSIR-IICT and BHEL partners to advance clean fuel technology: MoU signed on CO2 to DME"

19 Apr 2024 | 7:23 PM

Hyderabad, April 19 (UNI) The Council of Scientific and Industrial Research-Indian Institute of Chemical Technology (CSIR-IICT) and Bharat Heavy Electricals Limited (BHEL) Corporate R&D have forged a partnership to develop technology for capturing and converting carbon dioxide (CO2) to Dimethyl Ether (DME) through direct catalytic conversion.

see more..

Amara Raja Infra Wins Greenko’s 700MWp solar project in AP

19 Apr 2024 | 6:41 PM

Hyderabad, Apr 19 (UNI) Amara Raja Infra Private Limited (ARIPL), part of the $1.75 billion Amara Raja Group, on Friday announced it has secured a solar BoS (Balance of System) project of 500MW/700MWp from Greenko.

see more..
Sensex recovers 600 points on heavy buying on last day of week

Sensex recovers 600 points on heavy buying on last day of week

19 Apr 2024 | 5:34 PM

Mumbai, April 19 (UNI) Snapping a losing streak of last four sessions, the BSE Sensex on Friday bounced back 599.34 points to close at 73088.33 on expectation of minimal escalation of tension between Israel and Iran.

see more..

19 Apr 2024 | 5:24 PM

Mumbai, Apr 19 (UNI) IT major Wipro on Friday reported 7.80% year-on-year dip in consolidated net profit at Rs 2,834.6 crore for January-March quarter (Q4) of the financial year 2023-24.

see more..
Rupee up 8 paise against USD

Rupee up 8 paise against USD

19 Apr 2024 | 5:05 PM

Mumbai, April 19 (UNI) The Rupee on Friday ended positive at 83.47, rising 8 paise against the USD on selling US Dollar by bankers and exporters, dealers at the Foreign exchange said.

see more..
image